Goldstein LB, et al. (2006). Primary prevention of
ischemic stroke: A guideline from the American Heart Association/American
Stroke Association Stroke Council. Stroke, 37(6):
Wang WC (2009). Sickle cellanemia and other sickling
syndromes. In JP Greer et al., eds., Wintrobe's Clinical Hematology, 12th ed., pp. 1038-1082. Philadelphia: Lippincott Williams
Steinberg MH (2008). Sickle cell disease and
associated hemoglobinopathies. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1217-1226. Philadelphia:
Other Works Consulted
American Academy of Pediatrics, et al. (2003,
reaffirmed 2007). Policy statement: Eye examination in infants, children, and
young adults by pediatricians. Pediatrics, 111(4):
Brawley OW, et al. (2008). National Institutes of
Health consensus development conference statement: Hydroxyurea treatment for
sickle cell disease. Annals of Internal Medicine,
Committee on Genetics, American Academy of Pediatrics (2002, reaffirmed 2006). Health supervision for children with sickle cell disease. Pediatrics, 109(3): 526-535.
Hirst C, Owusu-Ofori S (2002). Prophylactic
antibiotics for preventing pneumococcal infection in children with sickle cell
disease. Cochrane Database of Systematic Reviews (3).
Oxford: Update Software.
Natarajan K, et al. (2010). Disorders of hemoglobin structure: Sickle cell anemia and related abnormalities. In K Kaushansky et al., eds., Williams Hematology, 8th ed., pp. 709-741. New York: McGraw-Hill.
National Heart, Lung, and Blood Institute, National
Institutes of Health (2002). The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Available online:
U.S. Preventive Services Task Force (2007). Screening for Sickle Cell Disease in Newborns. Available online: http://www.ahrq.gov/clinic/uspstf/uspshemo.htm.